Next-Generation Luminescence-Based Radiation Therapy Platform

Publication ID: 24-11857806_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Luminescence-Based Radiation Therapy Platform,” Published Technical Disclosure No. 24-11857806_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857806_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,806.

Summary of the Inventive Concept

A comprehensive radiation therapy system leveraging advanced luminescence-based sensors, machine learning, and real-time feedback to optimize treatment outcomes and minimize side effects.

Background and Problem Solved

Conventional radiation therapy often lacks real-time optimization, leading to suboptimal treatment outcomes and increased risk of radiation-induced toxicity. The original patent's luminescence-based method for precise delivery of ion beam therapy, while innovative, has limitations in terms of real-time optimization and personalized treatment planning. The new inventive concept addresses these limitations by integrating advanced sensors, machine learning, and real-time feedback to create a next-generation radiation therapy platform.

Detailed Description of the Inventive Concept

The new inventive concept comprises a luminescence-based sensor array for detecting ion beam fluence and energy distribution, a machine learning module for predicting optimal radiation therapy parameters, and a radiation therapy control system for adjusting ion beam delivery in response to said predicted parameters. This system enables real-time optimization of radiation therapy, ensuring that the ion beam is delivered with optimal energy and fluence to maximize treatment efficacy while minimizing side effects. Additionally, the system can be integrated with personalized radiation therapy planning, allowing for simulation-based optimization of treatment parameters based on individual patient anatomy and tumor characteristics.

Novelty and Inventive Step

The new inventive concept's integration of luminescence-based sensors, machine learning, and real-time feedback represents a significant departure from the original patent's method, which relied on static marker placement and lacked real-time optimization capabilities. The novel combination of these elements enables a paradigm shift in radiation therapy, allowing for truly personalized and optimized treatment outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different luminescent materials, sensor geometries, or machine learning algorithms. Variations could also include the integration of additional modalities, such as imaging or robotics, to further enhance treatment outcomes.

Potential Commercial Applications and Market

The next-generation radiation therapy platform has significant commercial potential in the oncology market, with potential applications in hospitals, cancer centers, and research institutions. The system's ability to optimize treatment outcomes and minimize side effects could lead to increased adoption and market share, potentially disrupting the traditional radiation therapy market.

Field of Art

Radiation oncology and medical physics, with expertise in ion beam therapy, luminescence-based dosimetry, and advanced radiation treatment technologies

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in medical physics, radiation oncology, or biomedical engineering, possessing knowledge of radiation therapy techniques, sensor technologies, and computational modeling approaches

Obviousness Rationale

A PHOSITA would recognize that the PTD's integration of machine learning and real-time sensor feedback represents a natural progression of the source patent's luminescence-based radiation therapy approach. The core concept of using luminescent markers for precise ion beam delivery is extended through predictable technological advancements in sensor array design and computational optimization. The variations demonstrate incremental improvements that would be obvious to a skilled practitioner seeking to enhance radiation therapy precision and personalization.

Obvious Combinations & Variations

Source Patent Element
EUD4TEA-inclusive marker for guiding ion beam radiation therapy
PTD Variation
Luminescence-based sensor array with machine learning for real-time beam parameter adjustment
Obviousness Reasoning
Predictable extension of existing marker technology using known machine learning techniques to improve treatment precision
Source Patent Element
Static marker placement for radiation targeting
PTD Variation
3D anatomical modeling and simulation-based treatment parameter optimization
Obviousness Reasoning
Obvious application of computational modeling techniques to personalize radiation therapy based on individual patient characteristics
Source Patent Element
Ion beam radiation delivery method
PTD Variation
Multi-tumor simultaneous treatment with coordinated sensor-based feedback
Obviousness Reasoning
Logical scaling of existing radiation therapy approach using known sensor coordination and control system technologies
Source Patent Element
Luminescence-based radiation marker detection
PTD Variation
Wearable radiation exposure monitoring device with predictive health effect analysis
Obviousness Reasoning
Natural progression of radiation detection technology using standard wireless and machine learning integration techniques
Source Patent Element
Radiation therapy targeting method
PTD Variation
Combinatorial materials development using machine learning for luminescent material selection
Obviousness Reasoning
Predictable application of computational screening techniques to materials science and radiation therapy technology
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857806 and the published technical disclosure, a person of ordinary skill in the art would find the claimed variations obvious through standard technological progression, combining known radiation therapy techniques with computational optimization approaches. The disclosed innovations represent incremental advancements that would be readily conceived by a skilled practitioner seeking to improve ion beam radiation delivery precision and personalization.

Original Patent Information

Patent NumberUS 11,857,806
TitleLuminescence-based method for precise delivery of ion beam therapy
Assignee(s)United States of America as represented by the Secretary of the Navy